LoginGet started
Picture of Everest Medicines logo

1952 — Everest Medicines Income Statement

0.000.00%
hk flag iconLast trade - 00:00
HealthcareHighly SpeculativeMid CapMomentum Trap
Balance sheetIncome statementCashflow
Subscribe to view all data

Annual income statement for Everest Medicines, fiscal year end - December 31st, CNY millions except per share, conversion factor applied.

2019
December 31st
2020
December 31st
2021
December 31st
2022
December 31st
2023
December 31st
Period Length:12 M12 M12 M12 M12 M
Source:PROSPECTUSARSARSARSARS
Standards:
IFRS
IFRS
IFRS
IFRS
IFRS
Status:FinalFinalFinalFinalFinal
Revenue
Total Revenue000.05412.8126
Cost of Revenue
Gross Profit——0.0318.1591.5
Selling / General / Administrative Expenses
Research And Development
Depreciation and Amortization
Unusual Expense / Income
Other Operating Expenses
Total Operating Expenses1766881,0262701,059
Operating Profit-176-688-1,026-257-933
Total Net Non Operating Interest Income / Expense
Other Net Non Operating Costs
Net Income Before Taxes-215-5,658-1,009-247-844
Provision for Income Taxes
Net Income After Taxes-215-5,658-1,009-247-844
Net Income Before Extraordinary Items
Net Income-215-5,658-1,009-247-844
Income Available to Common Shareholders Excluding Extraordinary Items
Income Available to Common Shareholders Including Extraordinary Items
Diluted Net Income-215-5,658-1,009-247-844
Diluted Weighted Average Shares
Basic EPS Including Extraordinary Items
Diluted EPS Including Extraordinary Items
Diluted EPS Excluding Extraordinary Items
Normalised Income Before Taxes
Normalised Income After Taxes
Normalised Income Available to Common Shareholders
Diluted Normalised EPS-1.08-66.3-3.44-3.68-2.53